Company attributes
Industry
B2X
Founder
AngelList URL
Pitchbook URL
Legal Name
MeiraGTx Holdings
Subsidiary
Legal classification
Date Incorporated
December 10, 2014
Spun Out From
Number of Employees (Ranges)
51 – 2000
Email Address
info@meiragtx.com0
Number of Employees
3330
Full Address
92 Britannia Walk, London, England, N1 7NQ
430 E 29TH St FL 10 New York, NY, 10016-8367 United States
Paalbergweg 2-4 1105AG Amsterdam The Netherlands0
450 East 29th Street, 14th Floor New York, NY 10016 United States0
34-38 Provost Street London N1 7NG United Kingdom0
CIK Number
Incorporation Reference
09348737
Investors
Founded Date
2015
0Total Funding Amount (USD)
7,580,000
Stock Symbol
MGTX0
Exchange
Latest Funding Type
Patents Assigned (Count)
2
Wellfound ID
Country
Other attributes
Company Operating Status
Active
Ticker Symbol
MGTX
UKSIC Code
72110
MeiraGTx is a clinical-stage gene therapy company developing treatments for patients with clinical developments including ocular indications, a salivary gland condition, and a Parkinson's disease program.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
